MARKET

ZYME

ZYME

Zymeworks
NYSE

Real-time Quotes | Nasdaq Last Sale

43.50
-0.60
-1.36%
Opening 10:24 01/28 EST
OPEN
44.20
PREV CLOSE
44.10
HIGH
44.26
LOW
42.66
VOLUME
98.26K
TURNOVER
--
52 WEEK HIGH
52.75
52 WEEK LOW
14.05
MARKET CAP
1.93B
P/E (TTM)
-25.2452
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ZYME and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ZYME News

  • Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option to Purchase Additional Shares
  • Business Wire.1d ago
  • Benzinga's Top Upgrades, Downgrades For January 23, 2020
  • Benzinga.4d ago
  • Zymeworks prices $279M equity offering
  • seekingalpha.4d ago
  • The Daily Biotech Pulse: Roche Reports Positive SMA Data Readout, Vir Biotech To Work On Virus Treatment
  • Benzinga.5d ago

More

Industry

Biotechnology & Medical Research
+1.32%
Pharmaceuticals & Medical Research
+0.66%

Hot Stocks

Name
Price
%Change

About ZYME

Zymeworks Inc is a Canada-based biopharmaceutical company. The Company specializes in the discovery, development and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer. The Company operates through a number of platforms, including Azymetric platform, which is developed for the development of IgG-like, novel bispecific antibodies for the targeting of synergistic drug targets; Albucore platform, which is developed as a flexible and alternative platform to antibodies where it is advantageous for multi-valent therapeutic to target multiple disease targets; Effect, which comprises a library of Fc modifications that can selectively modulate the activity of recruited immune cells, and the ZymeLink Conjugation platform, which is a suite of novel protein site-specific conjugation technologies and customizable cleavable and non-cleavable linkers that is compatible with a variety of small molecule therapeutics.
More

Webull offers Zymeworks Inc (ZYME) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.